Q3 FY2024 Earnings
Financial report interval: 2024.06.30 - 2024.09.30
Overview: Biora Therapeutics(BIOR) the Revenue is 32 K (--%);the EPS is -5.04 (+89.7%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
----
----
EPS
-5.037789.70%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf